Trauma Implants Market By Product, By Material Type, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market

CHAPTER 4: TRAUMA IMPLANTS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Screws
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Plates
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Interlocking Nails
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Bioabsorbable Fixators
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Others
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country

CHAPTER 5: TRAUMA IMPLANTS MARKET, BY MATERIAL TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Metallic Biomaterials
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Metallic Biomaterials Trauma Implants Market by type
5.2.4.1 Stainless Steel Market size and forecast, by region
5.2.4.2 Titanium Market size and forecast, by region
5.2.4.3 Others Market size and forecast, by region
5.3 Bioabsorbable material
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country

CHAPTER 6: TRAUMA IMPLANTS MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Orthopedic Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country

CHAPTER 7: TRAUMA IMPLANTS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Material Type
7.2.3.1 North America Metallic Biomaterials Trauma Implants Market by type
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Material Type
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Material Type
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Material Type
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Material Type
7.3.3.1 Europe Metallic Biomaterials Trauma Implants Market by type
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Material Type
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Material Type
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Material Type
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Material Type
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Material Type
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Material Type
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Material Type
7.4.3.1 Asia-Pacific Metallic Biomaterials Trauma Implants Market by type
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Material Type
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Material Type
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Material Type
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Material Type
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Material Type
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Material Type
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Material Type
7.5.3.1 LAMEA Metallic Biomaterials Trauma Implants Market by type
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Material Type
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Material Type
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Material Type
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Material Type
7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Players
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES
9.1 Conformis
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Globus Medical Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Johnson & Johnson (Depuy Synthes)
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 B. Braun Melsungen Ag
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Bioretec Ltd,
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Colson Medical Llc (Acumed)
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Medtronic Plc,
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Orthofix Medical, Inc
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Siora Surgicals Pvt. Ltd.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Smith & Nephew plc
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 Stryker Corporations
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 Zimmer Biomet Holdings
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments

Executive Summary

According to this report, titled, 'Trauma Implants Market,' the trauma implants market size was valued at $8.4 billion in 2021, and is estimated to reach $15.2 billion by 2031, growing at a CAGR of 6.1% from 2022 to 2031.

Trauma implants are artificial devices that are used to replace missing joints or provide mechanical support to fractured bone. The orthopedists use artificial implants for hips, knees, and ankle bone deformities, which allow patients to regain full range of motion. Trauma implants are made from metallic materials such as stainless steel, titanium, and cobalt alloys, whereas some are made from bioabsorbable materials such as polylacytic acid (PLA), polyglycolic acid (PGA), and lactic acid-co-glycolic acid. Trauma implants can be temporary or permanent and can be removed after fracture is recovered. Furthermore, they are available in different types such as metallic screws, metallic plates, K-wires, and staples.

Factors that drive growth of global trauma implants market include technological advancement in trauma implants and availability of advanced medical facilities in developed and developing countries such as U.S., Germany, Japan, and UK. Furthermore, surge in number of cases with extremity fracture due to different accidents and rise in patients undergoing traumatic injury surgeries contribute toward the growth of the global market. In addition, rise in geriatric population is the major factor propelling the growth of trauma implants market. People aged over 60 years are more susceptible to orthopedic disorders, thus being the major user of trauma implants.

Increase in awareness about advanced trauma implants among the healthcare professional is the key factor expected to provide growth opportunities for trauma implants market in developing countries such as China and India. Furthermore, surge in in product approval & product innovation strategies by the key market players such as J&J, Bioretec Ltd, and Stryker Corporation, and rise in R&D activities are some trauma implants market trends which anticipated to provide opportunities for the growth of the market.

However, high cost of surgical treatments and risks associated with the implants such as infection and connective tissue disease negatively affect the trauma implants market growth. For instance, the total cost of care per patient for trauma implant surgery is $35,585.5, which is relatively high.

COVID-19 is an acute disease in humans caused by a coronavirus, which is characterized mainly by fever and cough and is capable of progressing to severe symptoms and in some cases death, especially in older people and those with underlying health conditions. The COVID-19 pandemic has resulted in significant decline in demand for the trauma implants across healthcare sector which negatively impacted growth of trauma implants industry. Furthermore, patients getting treatment for traumatic injuries in hospitals were at risk of infection. This is the major factor for slowed down market growth of trauma implants. However, the market is expected to witness recovery in the forecast period, and show stable growth for trauma implants in the coming future.

Depending on product, screws segment was the major revenue contributor in 2021, owing to rise in demand of metallic screws and increase in surgeries performed for traumatic injuries. However, bioabsorbable fixators segment is expected to register highest CAGR of 6.9% during the forecast period, owing to increased use of bioabsorbable fixators in tibial & femoral fractures repairment and other soft tissue repairment surgeries. Furthermore, increase in R&D activities by market key players to develop inert bioabsorbable fixators propels the growth of the market.

On the basis of material type, metallic biomaterials segment was the major revenue contributor in 2021, owing to various advantages such as inert in nature, high fracture toughness, and corrosion resistance. However, bioabsorbable material is expected to register highest CAGR of 6.9% during the forecast period, owing to radiolucency property of bioabsorbable biomaterials, reduced need for hardware removal. For instance, High Density Polyethylene reinforced with Hydroxyapatite is largely used in manufacturing of bioabsorbable implants.

Region wise, North America has the highest trauma implants market share in 2021, and is expected to maintain its lead during the forecast period, owing to rise in prevalence of road traffic accident cases, availability of reimbursement policies in the region, and increase in demand for trauma implant products. However, Asia-Pacific is expected to register highest CAGR of 7.4% during the forecast period, owing to rise in geriatric population suffering from osteoporosis and other bone related disorders, increase in demand for trauma implant devices, and rise in initiatives taken by government for providing better healthcare facilities.

KEY FINDINGS OF THE STUDY

• By product, screws segment was highest contributor to the market in 2021.
• On the basis of material type, metallic biomaterials dominated the market in 2021.
• Based on end user, hospitals dominated the market in 2021.
• Based on region North America dominated the market in 2021, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Companies Mentioned

• Conformis
• Globus Medical Inc.
• Johnson & Johnson (Depuy Synthes)
• B. Braun Melsungen AG
• Bioretec Ltd.
• Colson Medical LLC (Acumed)
• Medtronic PLC
• Orthofix Medical, Inc.
• Siora Surgicals Pvt. Ltd.
• Smith & Nephew PLC
• Stryker Corporations
• Zimmer Biomet Holdings

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.